Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.490
-0.060 (-10.91%)
Mar 9, 2026, 3:22 PM EDT - Market open
Harvard Bioscience Employees
As of December 31, 2024, Harvard Bioscience had 355 total employees, including 330 full-time and 25 part-time employees. The number of employees decreased by 61 or -14.66% compared to the previous year.
Employees
355
Change (1Y)
-61
Growth (1Y)
-14.66%
Revenue / Employee
$246,115
Profits / Employee
-$151,648
Market Cap
21.91M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Jin Medical International | 273 |
| Retractable Technologies | 227 |
| Bionano Genomics | 100 |
| Precision Optics Corporation | 90 |
| Femasys | 71 |
| Ekso Bionics Holdings | 55 |
| Sharps Technology | 55 |
| Nephros | 31 |
HBIO News
- 2 days ago - Harvard Bioscience Announces Reverse Stock Split - GlobeNewsWire
- 6 days ago - Harvard Bioscience to Participate in KeyBanc's Virtual Healthcare Forum - GlobeNewsWire
- 11 days ago - Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET - GlobeNewsWire
- 27 days ago - Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas - GlobeNewsWire
- 5 weeks ago - Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth - GlobeNewsWire
- 2 months ago - Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package - GlobeNewsWire
- 4 months ago - Harvard Bioscience, Inc. (HBIO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Harvard Bioscience Announces Third Quarter 2025 Financial Results - GlobeNewsWire